Art

J-GLOBAL ID：201502299795812410   Reference number：15A0744302

Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes

過体重/肥満の日本人2型糖尿病症例に対するリラグルチド単独療法の有効性と安全性(メトホルミンとの比較)

Author (13)： TANAKA Kumiko (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN) ,  SAISHO Yoshifumi (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN) ,  KAWAI Toshihide (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN) ,  TANAKA Masami (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN) ,  MEGURO Shu (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN) ,  IRIE Junichiro (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN) ,  IMAI Takatoshi (Dep. of Internal Medicine, Yokohama Municipal Citizens’ Hospital, Kanagawa, JPN) ,  SHIGIHARA Toshikatsu (Dep. of Internal Medicine, Eiju General Hospital, Tokyo, JPN) ,  MORIMOTO Jiro (Dep. of Internal Medicine, Japan Community Health Care Organization Saitama Medical Center, Saitama, JPN) ,  YAJIMA Ken (Dep. of Internal Medicine, Federation of National Public Serv. Personnel Mutual Aid Associations, Tachikawa Hospital ...) ,  ATSUMI Yoshihito (Diabetes Center, Eiju General Hospital, Tokyo, JPN) ,  TAKEI Izumi (Dep. of Internal Medicine, Tokyo Dental Coll. Ichikawa General Hospital, Chiba, JPN) ,  ITOH Hiroshi (Dep. of Internal Medicine, Keio Univ. School of Medicine, Tokyo, JPN)
Material： Endocrine Journal  (Endocr J)
Volume： 62  Issue： 5  Page： 399-409 (J-STAGE)  Publication year： 2015 
JST Material Number： F0625A  ISSN： 0918-8959  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： Liraglutide ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0744302&from=J-GLOBAL&jstjournalNo=F0625A") }}

JST classification (1)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (1)： Metformin

Reference (41)：

• 1. International Diabetes Federation (2013) IDF Diabetes Atlas, 6th edn. Available from http://www.idf.org/diabetesatlas
• 2. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375: 2215-2222.
• 3. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, et al. (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364: 829-841.
• 4. Tobias DK, Pan A, Jackson CL, O’Reilly EJ, Ding EL, et al. (2014) Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 370: 233-244.
• 5. Kramer CK, Zinman B, Retnakaran R (2013) Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 159: 758-769.

Terms in the title (10)： 過体重 ,  肥満 ,  日本人 ,  2型糖尿病 ,  症例 ,  リラグルチド ,  単独療法 ,  有効性 ,  安全性 ,  メトホルミン